News Focus
News Focus
Followers 0
Posts 187
Boards Moderated 0
Alias Born 11/09/2007

Re: DewDiligence post# 10267

Friday, 02/08/2013 11:07:03 AM

Friday, February 08, 2013 11:07:03 AM

Post# of 20689
Thanks. That's helpful.

Given that timeline, the Obama administration's goal of reducing health care costs, and the May, 2014 patent expiration, the chances of seeing approval this year are decent. (20 to 30 percent? A WAG of course.)

All this assumes, of course, that MNTA was able to replicate Copaxone, which I believe they have.